Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NR1I3 agonists(Constitutive androstane receptor agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H15Cl2N3O2 |
InChIKeyUAKNSRDQWPLPHH-LGJNPRDNSA-N |
CAS Registry2259710-64-8 |